Grant: Master's Award: Canada Graduate Scholarships
University of Alberta
$17,500.00
Glucocorticoid Action in the Hindbrain Regulates Hepatic Triglyceride Release
FY 2022-23
Summary
Background: Elevated levels of circulating triglyceride (TG)-rich very low-density lipoproteins (VLDL-TGs) are associated with increased glucocorticoid (GC) action. GCs have extensive roles in lipid metabolism via direct actions on peripheral organs, including the liver and adipose tissue. However, how GCs modulate lipid metabolism via their actions in the brain is less recognized. The dorsal vagal complex (DVC) is an important brain region involved in whole-body metabolism. Here, I aim to assess how GCs signal in the DVC and affect hepatic VLDL-TG secretion. We hypothesize that direct GC infusion into the DVC stimulates hepatic triglyceride secretion.
Methods: Male and female Sprague-Dawley rats will undergo cannulation surgeries to target specific nuclei of the DVC and vascular catheterizations to enable simultaneous direct DVC infusions of treatments, intravenous injection of poloxamer 407, and blood sampling. VLDL-TG secretion studies will be done in 10h-fasted rats after intravenous poloxamer injection with concurrent DVC infusions. I will also test whether inhibiting GC action selectively in the DVC will improve lipid metabolism in diet-induced insulin-resistant rats. Plasma collected during the experiment will be assayed for TGs, hormones, proteins, etc. Tissues collected at the end of the experiment will be analyzed for gene expression, protein levels, and protein activity.
Expected Benefits: This study will further our knowledge on how GCs act in the DVC and their role in lipid metabolism. The results obtained from this study will provide groundwork for future studies that could aim at developing novel therapeutics to target brain GC signalling targets to restore aberrant lipid metabolism in individuals suffering from metabolic diseases.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
486039
Name
Vasilev Boyan
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Glucocorticoid Action in the Hindbrain Regulates Hepatic Triglyceride Release
Programtype2
Studentship Programs
Orgnameinp2
University of Alberta
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Adipose; Brain; Diabetes; Glucocorticoids; Lipids; Liver; Metabolism; Obesity; Triglyceride; Vldl
Abstract
Background: Elevated levels of circulating triglyceride (TG)-rich very low-density lipoproteins (VLDL-TGs) are associated with increased glucocorticoid (GC) action. GCs have extensive roles in lipid metabolism via direct actions on peripheral organs, including the liver and adipose tissue. However, how GCs modulate lipid metabolism via their actions in the brain is less recognized. The dorsal vagal complex (DVC) is an important brain region involved in whole-body metabolism. Here, I aim to assess how GCs signal in the DVC and affect hepatic VLDL-TG secretion. We hypothesize that direct GC infusion into the DVC stimulates hepatic triglyceride secretion.
Methods: Male and female Sprague-Dawley rats will undergo cannulation surgeries to target specific nuclei of the DVC and vascular catheterizations to enable simultaneous direct DVC infusions of treatments, intravenous injection of poloxamer 407, and blood sampling. VLDL-TG secretion studies will be done in 10h-fasted rats after intravenous poloxamer injection with concurrent DVC infusions. I will also test whether inhibiting GC action selectively in the DVC will improve lipid metabolism in diet-induced insulin-resistant rats. Plasma collected during the experiment will be assayed for TGs, hormones, proteins, etc. Tissues collected at the end of the experiment will be analyzed for gene expression, protein levels, and protein activity.
Expected Benefits: This study will further our knowledge on how GCs act in the DVC and their role in lipid metabolism. The results obtained from this study will provide groundwork for future studies that could aim at developing novel therapeutics to target brain GC signalling targets to restore aberrant lipid metabolism in individuals suffering from metabolic diseases.
Competitiondate
202212
Approvedterm2
1 yr 0 mth
Pinamesdelim
Vasilev, Boyan
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~